The novel anti-cancer feature of Brazzein through activating of hTLR5 by integration of biological evaluation: molecular docking and molecular dynamics simulation
Crossref DOI link: https://doi.org/10.1038/s41598-022-26487-2
Published Online: 2022-12-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Poursalim, Maede
Shasaltaneh, Marzieh Dehghan
Jafarian, Vahab
Salehabadi, Hafezeh
Text and Data Mining valid from 2022-12-20
Version of Record valid from 2022-12-20
Article History
Received: 13 August 2022
Accepted: 15 December 2022
First Online: 20 December 2022
Competing interests
: The authors declare no competing interests.